CSIMarket
 
Establishment Labs Holdings Inc   (NASDAQ: ESTA)
 
Price: $75.2900 $1.00 1.346%
Day's High: $75.76000213623047 Week Perf: 8.25 %
Day's Low: $ 72.31 30 Day Perf: -2.75 %
Volume (M): 433,619 52 Wk High: $ 97.59
Volume (M$): $ 0 52 Wk Avg: $68.26
Open: $74.08 52 Wk Low: $36.53



 Market Capitalization (Millions $) 2,268
 Shares Outstanding (Millions) 30
 Employees 1,004
 Revenues (TTM) (Millions $) 245
 Net Income (TTM) (Millions $) -39
 Cash Flow (TTM) (Millions $) 13
 Capital Exp. (TTM) (Millions $) 9

Business Description


Establishment Labs Holdings Inc is a medical technology company that designs, develops, manufactures, and markets breast implants and other medical devices.
The company, which is headquartered in Costa Rica, was founded in 2004 and went public on the NASDAQ stock exchange in 2018.
The company's main product is the Motiva Implant Matrix, a silicone breast implant that is designed to be more natural-looking and feel more like real breast tissue than traditional implants.
The Motiva Implant Matrix uses a proprietary silicone gel formula and a micro-textured surface to create a breast implant that is both safe and aesthetically pleasing.
In addition to its breast implants, Establishment Labs also offers a range of other medical devices, including tissue expanders, surgical instruments, and other surgical solutions.
The company has a global presence, with sales and distribution operations in over 50 countries worldwide.
It has manufacturing facilities in Costa Rica and is also expanding its manufacturing capabilities to other regions, including Europe and the United States.
Overall, Establishment Labs is an innovative medical technology company that is focused on developing and manufacturing safe and effective medical devices for the global market.
Its primary focus on breast implants is unique in the medical device industry and has helped the company carve out a niche in this growing market.


   Company Address: 11401 Century Oaks Terrace Austin 78758 TX
   Company Phone Number: 924-5072   Stock Exchange / Ticker: NASDAQ ESTA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ANIK        0.81% 
BDX   -4.79%    
MDXG        2.86% 
OSUR   -5.57%    
RCEL        3.07% 
SMTI        0.49% 
• View Complete Report
   



Business Update

Establishment Labs Holdings Inc. (NASDAQ ESTA), a prominent player in the field of medical technology, cont...

Published Tue, Feb 18 2025 5:02 PM UTC

Establishment Labs Unveils Preserv in Brazil, Pioneering a New Era in Breast Aesthetics and Reconstruction Establishment Labs Holdings Inc. (NASDAQ: ESTA), a prominent player in the field of medical technology, continues to lead the charge in enhancing women s health and wellness, particularly in the realm of breast aesthetics and reconstruction. In a significant move, the c...

Business Update

Establishment Labs on the Rise A New Era in Women’s Health and Breast Aesthetics

Published Tue, Jan 7 2025 1:56 PM UTC

Establishment Labs Holdings Inc. (NASDAQ: ESTA) is making waves in the medical technology sector, focusing on women s health and wellness, particularly in breast aesthetics and reconstruction. As the company gears up for its presentation at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, there are several significant developments that highlight its ...

Business Update

Establishment Labs Enhances Breast Aesthetics with Groundbreaking FDA Approvals and Promising Mia Femtech Clini...

Published Thu, Oct 31 2024 1:36 PM UTC

In an era where women s health and wellness have become focal points in medical innovation, Establishment Labs Holdings Inc. continues to make significant strides in the domain of breast aesthetics and reconstruction. The company recently garnered attention at the 9th Annual World Symposium on Ergonomic Implants (WSEI) held in Barcelona, Spain, where it unveiled three-year c...

Business Update

Establishment Labs Releases 2024 Post Market Surveillance Report Amid Expanding U.S. Presence

Published Tue, Oct 15 2024 2:36 PM UTC

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a pioneering medical technology firm dedicated to enhancing women’s health and wellness, particularly in the realms of breast aesthetics and reconstruction, has recently published its 2024 Post Market Surveillance (PMS) Report. This announcement comes as the company moves into a significant growth phase, with broad shipping ...

Business Update

Revolutionary Leap in Breast Augmentation First U.S. Patients Receive Motiva Implants Following FDA Approval

Published Wed, Oct 2 2024 12:47 PM UTC

In a remarkable milestone for women’s health and aesthetics, Establishment Labs Holdings Inc. (NASDAQ: ESTA) has announced that the first U.S. patients have successfully received breast augmentations using the newly FDA-approved Motiva Implants. This significant achievement brings cutting-edge technology to the forefront of cosmetic and reconstructive procedures, marking a...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 9.25
Price to Sales (Expected) -
Price to Book 104.96
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.1
Working Capital Ratio 3.84
Leverage Ratio (MRQ) 15.29
Total Debt to Equity 12.11
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.31 $
Revenues (TTM) 8.14 $
Cash Flow (TTM) 0.45 $
Cash 2.36 $
Book Value 0.72 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 244,128
Net Income per Employee (TTM) -38,736
Receivable Turnover Ratio (TTM) 3.25
Inventory Turnover Ratio (TTM) 0.83
Asset Turnover Ratio (TTM) 0.7

Profitability Ratios Current
Gross Margin (MRQ) 70.64 %
Operating Margin (MRQ) -6.35 %
Net Margin (MRQ) -17.39 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Establishment Labs Holdings Inc's Segments
Non-US    123.08 % of total Revenue
United States    65.57 % of total Revenue

  Establishment Labs Holdings Inc Outlook

On February 27 2025 the Establishment Labs Holdings Inc provided following guidance

nnEstablishment Labs Holdings Inc. Reports Fourth Quarter and Full Year 2024 Financial Performance, Reaffirms 2025 Guidancenn

New York - Establishment Labs Holdings Inc. (NASDAQ: ESTA), a leading global medical technology enterprise focused on enhancing women's health and wellness, particularly in the fields of breast aesthetics and reconstruction, has announced its financial results for the fourth quarter and the full year ending December 31, 2024. In this report, the company has reaffirmed its guidance for the year 2025.

nnFourth Quarter Financial Performance and Future Prospectsnn

In the fourth quarter of 2024, Establishment Labs recorded revenues of $44.5 million, aligning with...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.